Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.44 |
| ▸ | DRD1 | P21728 | 4/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.44 |
| ▸ | HRH1 | P35367 | 3/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13740973 | 0.84 | CYP2D6 (0.52) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL9248220 | 0.84 | TSHR (0.41) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL9278864 | 0.82 | CYP2D6 (0.42) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL9300866 | 0.81 | CYP2D6 (0.41) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL31497259 | 0.81 | CYP2D6 (0.49) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL9302381 | 0.81 | CYP2D6 (0.41) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL4070519 | 0.81 | CYP2D6 (0.49) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL6395273 | 0.81 | CYP2D6 (0.41) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL10619140 | 0.79 | CYP2D6 (0.47) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 | |
| SCHEMBL6669910 | 0.77 | CYP2D6 (0.38) | CHRM2ADRA2ADRD1SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210403620-A1 | FUNCTIONALIZED POLY(2,6-DIMETHYL PHENYLENE OXIDE) OLIGOMERS CONTAINING DICYCLOPENTADIENE, METHOD OF PRODUCING THE SAME AND USE THEREOF | CPC CORP TAIWAN (TW) | 2021-12-30 | — | — | US | claimed |
| US-11208406-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | ENI S.P.A. (IT) | 2021-12-28 | — | — | US | claimed |
| US-11183645-B2 | Organic thin film and method for manufacturing organic thin film, organic electroluminescence element, display device, illumination device, organic thin film solar cell, thin film transistor, and coating composition | NIPPON HOSO KYOKAI (JP) | 2021-11-23 | — | — | US | claimed |
| CN-109970519-B | Functionalized poly (2, 6-dimethylphenylene ether) oligomers containing dicyclopentadiene, process for their production and their use | 台湾中油股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| EP-2998285-B1 | EXTRACTION OF CARBOXYLIC ACIDS FROM A DILUTE AQUEOUS STREAM | PURAC BIOCHEM BV (NL) | 2021-09-15 | — | — | EP | claimed |
| CN-108473486-B | Disubstituted diaryloxybenzoheterodiazole compounds | 埃尼股份公司 | 2021-06-01 | — | — | CN | claimed |
| CN-107710443-B | Organic thin film, method for producing organic thin film, organic electroluminescent element, display device, lighting device, organic thin film solar cell, thin film transistor, and coating composition | 日本放送协会 | 2019-12-17 | — | — | CN | claimed |
| EP-3568428-A1 | DELAYED CURING CATALYSTS FOR THIOL/EPOXY REACTIONS | PRC-Desoto International, Inc. (US) | 2019-11-20 | — | — | EP | claimed |
| EP-3374357-B1 | DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI SPA (IT) | 2019-10-02 | — | — | EP | claimed |
| CN-109970519-A | Functionalized poly (2,6- dimethyl phenylate) oligomer, its manufacturing method containing dicyclopentadiene and application thereof | 台湾中油股份有限公司 | 2019-07-05 | — | — | CN | claimed |
| US-4808731-A | CONTACTING SUBSTITUTED PHTHALIC ANHYDRIDE WITH DIALKYLAMINOPYRIDINE IN REFLUXING NONPOLAR SOLVENT | GENERAL ELECTRIC COMPANY (US) | 1989-02-28 | — | — | US | claimed |
| US-4804773-A | Production of gem-disubstituted cyclohexadienones | ETHYL CORPORATION (US) | 1989-02-14 | — | — | US | claimed |
| EP-0287340-A2 | Novel acylation process for the synthesis of HMG-COA reductase inhibitors | MERCK & CO. INC. (US) | 1988-10-19 | — | — | EP | claimed |
| EP-0147879-B1 | PROCESS FOR THE PREPARATION OF A HYDROXYLAMINE | AKZO N.V. (NL) | 1987-12-16 | — | — | EP | claimed |
| EP-0121112-B1 | 2'-DEOXY-3-PHOSPHONYLMETHYL NUCLEOSIDES AND METHOD FOR THEIR PREPARATION | Gesellschaft für Biotechnologische Forschung mbH (GBF) (DE) | 1987-05-13 | — | — | EP | claimed |
| EP-0218111-A1 | Process for the preparation of tetrafluorobenzoic acid | WARNER-LAMBERT COMPANY (US) | 1987-04-15 | — | — | EP | claimed |
| EP-0147879-A1 | Process for the preparation of a hydroxylamine | AKZO N.V. (NL) | 1985-07-10 | — | — | EP | claimed |
| EP-0140207-A2 | A process for rapidly curing a brominated fluoroelastomer | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-05-08 | — | — | EP | claimed |
| EP-0014103-B1 | IMPROVED PROCESS FOR THE MANUFACTURE OF CARBAMATES | THE HALCON SD GROUP, INC. (US) | 1983-05-11 | — | — | EP | claimed |
| US-4339616-A | AMINE SALTS AS CATALYSTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1982-07-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208406-B2 | Disubstituted diaryloxybenzoheterodiazole compounds | NR2E3, SCLY, NR2C2 | CHRM2 622/4885ADRA2A 3460/4885DRD1 431/4885 |
| US-20210403620-A1 | FUNCTIONALIZED POLY(2,6-DIMETHYL PHENYLENE OXIDE) OLIGOMERS CONTAINING DICYCLOPENTADIENE, METHOD OF PRODUCING THE SAME AND USE THEREOF | PUF60, PARG, PARP2 | CHRM2 2478/4885ADRA2A 3902/4885DRD1 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.